Search

for
Search:

GlossaryChlorpromazine (Thorazine)

antipsychotic medication used to treat schizophrenia and bipolar disorder

Chlorpromazine, also known as Thorazine, is an antipsychotic medication primarily used to treat schizophrenia and manic phases of bipolar disorder. It works by blocking dopamine receptors in the brain, which helps to reduce symptoms such as hallucinations, delusions, and agitation.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 36 results

Trazodone and Chlorpromazine: A Proposal Treatment for Post-Finasteride Syndrome and Post-Selective Serotonin Reuptake Inhibitors Syndrome

research Trazodone and Chlorpromazine: A Proposal Treatment for Post-Finasteride Syndrome and Post-Selective Serotonin Reuptake Inhibitors Syndrome

July 2023 in “Zenodo (CERN European Organization for Nuclear Research)”

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

research Nurses' Drug Alert: Findings and Updates from April 1987

1 citations , April 1987 in “American Journal of Nursing”

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

research Obstetric Dermatology

January 2009 in “Springer eBooks”

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

research Design and In Vitro Evaluation of Finasteride-Loaded Liquid Crystalline Nanoparticles for Topical Delivery

58 citations , December 2012 in “Aaps Pharmscitech”

LCN may improve finasteride delivery for hair loss treatment.

research Chitosan Microparticles for Sustaining the Topical Delivery of Minoxidil Sulphate

45 citations , August 2011 in “Journal of Microencapsulation”

Chitosan microparticles improve minoxidil sulphate delivery, potentially reducing daily applications.

View more "thorazine" in research →

Community Join

1 / 1 results

community Another blow to the cursed baldness

in Research/Science 91 upvotes 1 week ago

A South Korean company, Therazyne, has developed a promising hair loss treatment using a WNT chain surrogate that binds to Frizzled 7, with human follicle testing expected soon. Current treatments like minoxidil and finasteride are not seen as cures, and while optimism exists for future solutions like PP405, approval processes are lengthy.